To the community members in India.
A recent article in In-PharmaTechnologist cited greater regulatory action by the US FDA on Indian manufacturers
http://www.in-pharmatechnologist.com/Regulatory-Safety/Tighter-GMPs-a-significant-risk-for-Indian-drugmakers-CARE?nocount
Have those of you in India seen these effects? How are your companies responding?